TWA
TCI Wealth Advisors Portfolio holdings
AUM
$1.46B
1-Year Return
12.39%
This Quarter Return
+0.78%
1 Year Return
+12.39%
3 Year Return
+51.49%
5 Year Return
+94.48%
10 Year Return
+239.13%
AUM
$637M
AUM Growth
+$60.5M
(+11%)
Cap. Flow
+$63.1M
Cap. Flow
% of AUM
9.91%
Top 10 Holdings %
Top 10 Hldgs %
63.78%
Holding
2,681
New
319
Increased
1,115
Reduced
345
Closed
257
Top Buys
| 1 |
Dimensional International Value ETF
DFIV
|
+$33.2M |
| 2 |
Dimensional World ex US Core Equity 2 ETF
DFAX
|
+$16.1M |
| 3 |
Upstart Holdings
UPST
|
+$5.89M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$3.25M |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
+$2.74M |
Top Sells
| 1 |
Affirm
AFRM
|
+$3.71M |
| 2 |
Microsoft
MSFT
|
+$2.85M |
| 3 |
VanEck Preferred Securities ex Financials ETF
PFXF
|
+$630K |
| 4 |
Dimensional US Targeted Value ETF
DFAT
|
+$580K |
| 5 |
Coca-Cola
KO
|
+$539K |
Sector Composition
| 1 | Technology | 7.91% |
| 2 | Healthcare | 4.49% |
| 3 | Financials | 4.36% |
| 4 | Consumer Discretionary | 3.77% |
| 5 | Industrials | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Vail Resorts
MTN
$5.64B
| $3K | ﹤0.01% |
10
| – | – |
|
2027
Materion
MTRN
$2.34B
| $3K | ﹤0.01% |
50
+40
| +400% | +$2.4K |
|
2028
Manitowoc
MTW
$361M
| $3K | ﹤0.01% |
133
+25
| +23% | +$564 |
|
2029
Microvision
MVIS
$334M
| $3K | ﹤0.01% |
254
+83
| +49% | +$980 |
|
2030
National Healthcare
NHC
$1.8B
| $3K | ﹤0.01% |
49
| – | – |
|
2031
National Research Corp
NRC
$363M
| $3K | ﹤0.01% |
64
| – | – |
|
2032
NETSCOUT
NTCT
$1.78B
| $3K | ﹤0.01% |
109
| – | – |
|
|
NVEE
2033
DELISTED
NV5 Global
NVEE
| $3K | ﹤0.01% |
+140
| New | +$3K |
|
2034
New York Times
NYT
$9.58B
| $3K | ﹤0.01% |
59
-127
| -68% | -$6.46K |
|
2035
Orion
OEC
$592M
| $3K | ﹤0.01% |
+174
| New | +$3K |
|
2036
Opendoor
OPEN
$4.45B
| $3K | ﹤0.01% |
+142
| New | +$3K |
|
2037
Opko Health
OPK
$1.13B
| $3K | ﹤0.01% |
+840
| New | +$3K |
|
|
ORC
2038
Orchid Island Capital
ORC
$962M
| $3K | ﹤0.01% |
+123
| New | +$3K |
|
2039
Orrstown Financial Services
ORRF
$682M
| $3K | ﹤0.01% |
107
| – | – |
|
2040
OneSpan
OSPN
$598M
| $3K | ﹤0.01% |
182
+146
| +406% | +$2.41K |
|
2041
OraSure Technologies
OSUR
$238M
| $3K | ﹤0.01% |
+265
| New | +$3K |
|
2042
Ranpak Holdings
PACK
$416M
| $3K | ﹤0.01% |
+117
| New | +$3K |
|
2043
PAR Technology
PAR
$1.95B
| $3K | ﹤0.01% |
+47
| New | +$3K |
|
2044
Vaxcyte
PCVX
$4.21B
| $3K | ﹤0.01% |
+132
| New | +$3K |
|
2045
Precigen
PGEN
$1.24B
| $3K | ﹤0.01% |
679
+579
| +579% | +$2.56K |
|
2046
Pennant Group
PNTG
$847M
| $3K | ﹤0.01% |
110
+50
| +83% | +$1.36K |
|
2047
ProAssurance
PRA
$1.22B
| $3K | ﹤0.01% |
+144
| New | +$3K |
|
2048
PROS Holdings
PRO
$755M
| $3K | ﹤0.01% |
73
+21
| +40% | +$863 |
|
2049
Personalis
PSNL
$472M
| $3K | ﹤0.01% |
163
+68
| +72% | +$1.25K |
|
2050
Protagonist Therapeutics
PTGX
$3.5B
| $3K | ﹤0.01% |
146
+51
| +54% | +$1.05K |
|